Literature DB >> 7691429

Negative feedback regulation of endothelial cell function by nitric oxide.

G M Buga1, J M Griscavage, N E Rogers, L J Ignarro.   

Abstract

The objective of this study was to determine whether nitric oxide (NO) could function as a negative feedback modulator of endothelial cell function by inhibiting NO synthase in vascular endothelial cells. The rationale for this approach was a previous study from this laboratory, which revealed that NO inhibits neuronal NO synthase from rat cerebellum. In the present study, NO and NO-donor agents noncompetitively inhibited NO synthase derived from bovine aortic endothelial cells. Oxyhemoglobin blocked the inhibitory action of NO and by itself increased NO synthase activity. This finding suggests that NO acts as a negative feedback modulator of NO synthase. In intact aortic endothelial cells grown on microcarrier beads and perfused in a bioassay cascade system, pretreatment of cells with NO-donor agents caused a marked inhibition of endothelial NO biosynthesis in response to bradykinin and increased fluid shear or flow. When isolated bovine pulmonary arterial rings precontracted by phenylephrine were used, pretreatment of arterial rings with NO-donor agents diminished endothelium-dependent arterial relaxation involving the L-arginine-NO pathway without altering endothelium-independent relaxation to NO itself. On the basis of these studies, NO is suggested to play an important negative feedback regulatory role on endothelial NO synthase and, therefore, vascular endothelial cell function.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7691429     DOI: 10.1161/01.res.73.5.808

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  49 in total

1.  Arginine and nitrate tolerance.

Authors:  R J MacAllister
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

Review 2.  Quinapril: a further update of its pharmacology and therapeutic use in cardiovascular disorders.

Authors:  Christine R Culy; Blair Jarvis
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 3.  Control of coronary blood flow by autacoids.

Authors:  E Bassenge
Journal:  Basic Res Cardiol       Date:  1995 Mar-Apr       Impact factor: 17.165

Review 4.  Delivery and monitoring of inhaled nitric oxide.

Authors:  J D Young; O J Dyar
Journal:  Intensive Care Med       Date:  1996-01       Impact factor: 17.440

5.  Angiotensin II decreases nitric oxide synthase 3 expression via nitric oxide and superoxide in the thick ascending limb.

Authors:  Vanesa D Ramseyer; Jeffrey L Garvin
Journal:  Hypertension       Date:  2008-12-15       Impact factor: 10.190

6.  A synthetic analogue of 20-HETE, 5,14-HEDGE, reverses endotoxin-induced hypotension via increased 20-HETE levels associated with decreased iNOS protein expression and vasodilator prostanoid production in rats.

Authors:  Tuba Cuez; Belma Korkmaz; C Kemal Buharalioglu; Seyhan Sahan-Firat; John Falck; Kafait U Malik; Bahar Tunctan
Journal:  Basic Clin Pharmacol Toxicol       Date:  2009-12-07       Impact factor: 4.080

Review 7.  In search of a function for tetrahydrobiopterin in the biosynthesis of nitric oxide.

Authors:  B Mayer; E R Werner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-05       Impact factor: 3.000

8.  Inhibition of nitric oxide synthase activity in cerebral cortical synaptosomes by nitric oxide donors: evidence for feedback autoregulation.

Authors:  T W Vickroy; W L Malphurs
Journal:  Neurochem Res       Date:  1995-03       Impact factor: 3.996

9.  GTP cyclohydrolase I expression is regulated by nitric oxide: role of cyclic AMP.

Authors:  Sanjiv Kumar; Xutong Sun; Shruti Sharma; Saurabh Aggarwal; Kandasamy Ravi; Jeffery R Fineman; Stephen M Black
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-05-15       Impact factor: 5.464

10.  Regulation of M1 muscarinic receptor-mediated signaling in intact cells by exogenous, but not endogenously produced, nitric oxide.

Authors:  A M Parsons; J L Sorman; E E El-Fakahany
Journal:  Neurochem Res       Date:  1999-01       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.